Altogen Labs is a preclinical research organization specializing in the testing and evaluation of novel pharmacological and biological treatments, including novel anticancer therapies, medical ...

CROs are fundamental to the development of cancer treatments but face multiple challenges. We analyze the biggest trends in ...

To evaluate the 10 likely drugs involved, analysts evaluated Medicare spending, FDA approval date, and expected biosimilar entry; 4 of the drugs are expected to be hematology/oncology products.

The legalization of recreational marijuana in Minnesota has created daily conversations about how to incorporate the use of ...

Jim Furniss and Chris Teale discuss the market access environment for new oncology products in Europe, including sales comparisons with the US and their thoughts on the future. What do we mean by ...

Analyst Silvan Tuerkcan of JMP Securities maintained a Buy rating on Relay Therapeutics (RLAY – Research Report), retaining the price ...

The conference, taking place in Salt Lake City, Utah from September 11 to 13, is a premier event for pediatric ...

Vadodara: Alembic Pharma has announced that Sudhakar Pandiyan has been appointed as Head - Technical Operations (Sterile & ...

High CEACAM1 and low PDL1 expression in tumors, as well as their combination identified as potential biomarkers associated ...

Adela’s tissue-agnostic MRD test has been clinically validated to predict and surveil for recurrence in patients with head & ...